Monica Steigerwald: Gilead Sciences announced its amazing allocation of $3.15 million to 22 organizations
Janice Cowden, Former nurse, cancer patient and advocate, shared a post by Monica Steigerwald, Vice President at Living Beyond Breast Cancer, on LinkedIn:
”This makes my heart happy!
Thanks to Gilead Sciences for supporting organizations that serve the metastatic breast cancer community and to Living Beyond Breast Cancer for providing support, advocacy training, education and a place to connect with others living with MBC through the helpline, and the annual Conference on MBC.
Thank you for recognizing that Stage IV Needs More taking action to educate, create awareness and provide resources for patients, caregivers and their families.
Immense gratitude to LBBC.org for providing me with the training needed to launch into patient advocacy in 2017 via Hear My Voice!”
Quoting Monica Steigerwald‘s post:
”Gilead Sciences recently announced its amazing allocation of $3.15 million to 22 organizations that supports the metastatic breast cancer community.
These organizations are providing services for patients and caregivers to increase patient centered decision making and supportive care. I’m thrilled to announce that Living Beyond Breast Cancer is one of those nonprofit organizations and is partnering with Jefferson’s Sidney Kimmel Cancer Center to create shared decision-making tools to help people living with metastatic breast cancer communicate their needs and concerns regarding treatment dosing plans and cadence protocols with health care providers.
Janice Cowden is a former nurse, cancer patient and advocate. She was diagnosed with stage I triple-negative early-stage breast cancer in 2011; later, Janice was diagnosed with metastatic disease in 2016. She became a Living Beyond Breast Cancer Hear My Voice (HMV) Advocate in 2017 and continues to serve as a Helpline Volunteer. Janice works with several patient-founded and -led organizations including PCDI, GRASP, and Project Life MBC. As a trained peer support volunteer, she is founder of an international online peer support group for patients newly diagnosed with MBC.
She serves on the Board of Directors for METAvivor Research and Support, Inc., and is an Advisory Board member for Project Life MBC. In 2022, she attended ASCO as a patient advocate scholarship recipient. In October 2022, she was invited to serve as a lead patient advocate, representing PCDI, on a research study with ASCO.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023